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ABSTRACT 
Objective:  To investigate outcome for Arnold Chiari 1 Malformation (ACM1) patients based on intervention 
methods, i.e., posterior fossa decompression without duraplasty and with duraplasty in terms of symptomatic and 
functional improvement. 
Materials and Methods:  This study was conducted prospectively over 41 months from January 2013 to May 
2016. Patients with confirmed diagnosis of ACM-1 were included in the study. Patients either underwent pos-
terior fossa decompression without duraplasty or with duraplasty, depending upon the severity of tonsillar 
descent, the presence of syrinx, neurological deficits or hydrocephalous. Data was collected on pre-designed pro 
forma both pre-operatively and during follow up. Outcome was assessed according to Chicago Chiari Outcome 
Scale (CCOS). Data analysis was done using SPSS v 22.0. 
Results:  Posterior Fossa Decompression (PFD) without dural opening was performed in 13 patients while in 8 
patients duraplasty was performed. Overall mean age was 32.95 ± 5.88 years and mean symptoms duration was 
21.62 ± 8.82 months. The most common complaints were headache (76.2%), neck pain (61.9%), hand and arm 
weakness (47.6%), gait disturbance (47.6%) and cranial nerve dysfunctions (76.2%). The median preop CCOS 
was 10 ± 1.57 while postoperative CCOS was 13 ± 2.27. There was a significant relief in terms of CCOS improve-
ment in preop and postoperative scores (P<0.0001). Similarly, on Chi-square analysis there was no significant 
difference between favourability of outcome for the two types of intervention. 50% favourable outcome was 
obtained for PFD without duraplasty and 50% for PFD with duraplasty. On Chi-square analysis, PFD with 
duroplasty was significantly associated with the occurrence of postoperative complications (p = 0.006). The 
commonest complication was CSF leak in 14.3% of patients. There was no mortality. No recurrent cases were 
noted during the 41-months study period. 
Conclusion:  Posterior fossa decompression forACM-I is simple and effective. Further studies regarding surgical 
outcome and development of outcome assessment are required with larger patient cohorts. 
Keywords:  Arnold Chiari Malformation, Posterior fossa decompression, Chicago Chiari Outcome Scale, 
Duraplasty. 
Abbreviations:  CCOS: The Chicago Chiari Outcome Scale. CSF: Cerebrospinal Fluid. CV: Craniovertebral. 
OPD: Out Patient Department. SD: Standard Deviation. HMC: Hayat Abad Medical Complex. ACM1: Arnold 
Chain 1 Malformation. 
 
INTRODUCTION 
Arnold-Chiari malformations are closely related abno-
rmalities of the craniovertebral (CV) junction. There 
are four types out of which the first two are the most 
prevalent subtypes.
1
 The more clinically important 
 
disorder, Arnold-Chiari Malformation type 1 (ACM1) 
is prevalent in young adults and may significantly aff-
ect neurological function of an individual.
2
 The treat-
ment of ACM1 is frequently surgical in symptom-
matic cases or when neurological deficits starts appea-
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ring. 
 The most widely used surgical intervention is 
posterior fossa decompression also called suboccipital 
decompression. Various modifications to this basic 
approach have been described in literature, the main 
aim of which is to open the shallow posterior fossa in 
order to allow room for the contents and relieve pre-
ssure on the brainstem. These modifications are, dural 
opening and repair with an expanding graft, C1 lami-
nectomy, tonsillectomy and shunting of associate syr-
inx.
3
 
 There is a difference of opinion regarding perfor-
ming posterior fossa decompression either with or 
without duraplasty. This difference in opinion origin-
nates from various studies reporting variable outcome 
for both approaches.
4,5
 The most acceptable argument 
regarding outcome for ACM1 surgery is the paucity of 
outcome measure instruments. There is no unified ins-
trument which can be used to measure postoperative 
long and short term outcome. Generally, neurological 
functional improvement, pain relief, gait improvement 
and a halt in the progression of the disease are belie-
ved to be considered during follow-up evaluation.
6,7
 
 The Chicago Chiari Outcome Scale (CCOS) was 
used by several authors to measure the postoperative 
course of patients. This scale has been subjected to 
critical external validation and found useful in tracking 
sensory, motor, functional improvements as well as the 
occurrence of postoperative complications.
8-10
 
 We aim to present out experience with the long-
term outcome of our patients who were operated for 
symptomatic ACM1 in terms of improvement in sym-
ptomatology, as well as functional improvement and 
complication occurrence. We hope that this will help 
understand the postoperative course of the disease and 
the amount of relief that can be provided with surgical 
decompression. 
 
MATERIALS AND METHODS 
This is a prospective study of 41 – month duration 
(January 2013 – May 2016) conducted at the depar-
tment of neurosurgery, Hayatabad Medical Complex 
Peshawar. Informed consent was obtained from all 
patients before inclusion in the study. Approval was 
also taken from the institutional ethical committee 
before commencement of the study. 
 All symptomatic patients with a confirmed diag-
nosis of ACM1 after outpatient and inpatient workup, 
between the ages of 16 and 65 years irrespective of 
their gender or ethnicity were included. Patients with 
significant trauma to the cervical or craniocervical 
junction, those with significant basilar invagination 
and those who were previously operated were exclude. 
Patients who were bed bound for more than 2 years 
were also excluded. 
 Patients with confirmed diagnosis of CM-I were 
admitted to the ward. A detailed preoperative history 
and examination were performed and the complaints 
were rated according to the CCOS. The preoperative 
MRI findings were also recorded about the level of the 
tonsillar herniation, the presence or absence of syrinx, 
platybasia, basilar invagination and the presence or 
absence of hydrocephalous. 
 The decision for dural opening was based on the 
presence of higher degree of tonsillar herniation, syrin-
gomyelia, severe long tract signs and multiple cranial 
nerves involvement. 
 
Operative Procedure 
After induction of GA, intravenousceftriaxone (1g) 
were administered. Patient was positioned prone with 
bony prominences well padded. A vertical midline 
incision was employed, exposing the occipital bone 
and downward up to C2 lamina. Suboccipital craniec-
tomy was performed in a standard manner with at least 
5×5 cm dimensions or more.C1 ring was removed alo-
ng with decompression of posterior fossa. 
 The duraplasty group received a dural opening in a 
Y-shaped manner, arachnoid adhesiolysis and expans-
ion duraplasty was performed using fascia lata, peri-
osteum or synthetic dural substitute followed by water 
tight closure. 
 
Follow-up 
Patients were called for follow-up at 2 weeks for their 
initial appointment and monthly for the first 6 months. 
Thereafter, 3 to 6 monthly follow-up was advised. All 
patients were assessed in OPD clinic according to the 
CCOS. Excellent outcome was recorded in those hav-
ing a score of 16 or more, functional outcome in those 
with a CCOS score of 12, impaired outcome with 
CCOS of 8 and incapacitated were those who had 4 or 
less CCOS. 
 
Data Analysis 
Data was entered and analysed using SPSS version 
22.0. Mean ± standard deviations were calculated for 
continuous variables, while frequency and percentages 
were calculated for categorical variables. A paired
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samples t-test was used 
to ascertain difference 
between pre- and post-
operative improvement 
or deterioration. 
 
RESULTS 
Patient 
Demographics 
21 patients were opera-
ted during the 41-mon-
th period, including 11 
males (52.4%) and 10 
females (47.6%) in a 
ratio of 1.1 to 1. Over-
all mean age was 32.95 
years ± 5.88 SD (range: 
20 – 45). The overall 
mean duration of sym-
ptoms was 21.6 months 
± 8.82 SD. Overall me-
dian CCOS was 10 ± 
1.58. The overall post-
operative median CC-
OS was 13 ± 2.27 SD. 
The overall mean len-
gth of stay (LoS) was 
6.57 ± 3.06 SD. 
 
Clinical Presentation 
& Perioperative 
Table 1: Clinical features of patients with ACM-1 and their distribution in the two 
treatment groups. 
 
Variable 
Decompression 
without Duraplasty 
N = 13 
Decompression 
with Duraplasty 
N = 8 
Significance 
Gender   0.1 
Male 5 (38.5%) 6 (75%)  
Female 8 (61.5%) 2 (25%)  
Headache 10 (76.9%) 6 (75%) 0.9 
Neck Pain 8 (61.5%) 5 (62.5%) 0.9 
Gait disturbance 6 (46.2%) 4 (50%) 0.8 
Upper limb weakness 7 (53.8%) 3 (37.5%) 0.5 
Muscle wasting 6 (46.2%) 5 (62.5%) 0.50 
Cranial nerve dysfunction 10 (76.9%) 6 (75%) 0.9 
Syrinx 7 (53.8%) 3 (37.5%) 0.5 
Complications   0.006 
CSF leak - 3 (37.5%) 0.01 
Pseudomeningocele - 2 (25%) 0.06 
Wound infection - 2 (25%) 0.06 
Meningitis - 1 (12.5%) 0.1 
Age (years) 32.69 ± 5.92 33.38 ± 6.19 0.8 
Symptoms duration (months) 22.92 ± 7.94 19.50 ± 10.29 0.4 
Preop CCOS 9.23 ± 1.3 10.63 ± 1.68 0.05 
Postop CCOS 12.15 ± 2.44 12.88 ± 2.03 0.5 
Length of Stay (days) 5.0 ± 1.35 9.13 ± 3.39 0.001 
 
Findings 
Headache was present in 16 
(76.2%) patients, neck pain 
in 13 (61.9%), gait distur-
bance in 10 (47.6%) and 
dysesthesias in 13 (61.9%). 
Upper limb weakness was 
present in 19 (47.6%), mus-
cle wasting in 11 (52.4%), 
cranial nerve dysfunction in 
16 (76.2%). 10 (47.6%) of 
patients had underlying syr-
inx, however, none of them 
were significant (> 2 mm 
diameter). 
 13 (61.9%) patients 
underwent posterior fossa
 
Table 2: Outcome representation for the two treatment types; shaded cells show 
decompression without duraplasty, clear cells show decompression with 
duraplasty. 
 
 1 2 3 4 
Pain 
- N = 2 (15.4%) N = 4 (30.8%) N = 7 (53.8%) 
- N = 2 (25%) N = 6 (75%) - 
Non-pain 
N = 4 (30.8%) N = 2 (15.4%) - N = 7 (53.8%) 
- N = 1 (12.5%) N = 2 (25%) N = 5 (62.5%) 
Functionality  
N = 2 (15.4%) N = 4 (30.8%) N = 5 (38.5%) N = 2 (15.4%) 
N = 1 (12.5%) N = 1 (12.5%) N = 5 (62.5%) N = 1 (12.5%) 
Complications 
N = 2 (15.4%) - N = 2 (15.4%) N = 9 (69.2%) 
N = 3 (37.5%) - - N = 5 (62.5%) 
Total score 4: Incapacitated 8: Impaired 12: Functional 16: Excellent 
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decompression without duraplasty while 8 (38.1%) of 
patients were operated by decompression plus dura-
plasty. 
 The mean follow-up duration was 18 months ± 5.6 
SD. Complications included CSF leak in 3 (14.3%), 
wound infection in 2 (9.5%), meningitis in 1 (4.8%) 
and pseudomeningocele in 2 (9.5%) of patients. 
 Overall the outcome as graded by CCOS was exc-
ellent in 6 (28.6%), functional improvement with some 
residual symptoms in 12 (57.1%) and 3 (14.3%) pati-
ents obtained very little improvement in their symp-
toms. 
 Table and Table represent the clinical features str-
atified for the two intervention techniques along with 
the Chi-square and independent samples t-statistics. 
 A paired samples t-test was performed to see the 
mean difference in preoperative and postoperative CC-
OS score. The correlation between pre- and postopera-
tive score was strong (0.61, p = 0.003). A mean differ-
rence of -2.67 ± 1.79 was obtained (95% CI: -3.5 to 
-1.8), with a t score = -6.8, and p value of < 0.0001. 
 
Outcome at Follow-up 
The mean postoperative Chicago Chiari Outcome 
Score for decompression without duraplasty was 12.1 
± 2.4while for the duraplasty group, it was 12.8 ± 2.03 
SD. The table below shows scores for both treatment 
groups with their frequencies and percentages. 
 
DISCUSSION 
ACM1 is a rare disorder of CV junction with a dege-
nerative and congenital component. There are various 
theories regarding its development. True incidence is 
yet unknown, Meadows J et al
11
 in MRIs of asym-
ptomatic cases estimated it to be approximately 1%. 
Out of these, nearly 20% are estimated to become 
symptomatic over the course of few years.
6,11,12
 
 MRI of the CV junction with posterior fossa and 
cervical spine cuts is the study of choice along with 
help obtained from multiplanar CT for evaluation of 
bony structures.
13,14
 Cine MRI is still used as a resea-
rch tool in studying the pathophysiology around CV 
junction.
15
 Posterior fossa volume can be estimated 
using MRI images and is helpful in deciding appro-
priate surgical modality.
16
 
 Decompression of the posterior fossa and upper C-
spine without opening the dura is one of the simplest 
surgical intervention. However, the biomechanics and 
pathophysiological findings around CV junction in 
ACM1 are not usually that simple and in some cases 
complex interventions such as dural opening, adhe-
siolysis, manual tonsillar reduction and expansion 
duraplasty are necessary. In the present study, we 
operated 13 patients without opening the dura and sim-
ple decompression of the posterior fossa with C1 lami-
nectomy while 8 patients were operated with dural 
opening, duraplasty and adhesiolysis. However, no 
cases required manual tonsillar reduction or amputat-
ion of the tonsils. The symptomatology improved in 
more than 75% of our patients while more than 60% 
achieved good functional outcome. Kennedy BC et al
6
 
has reported good to excellent outcome in 91% of their 
patients during the 3-year follow-up period while 
Chotai S et al
17
 has shown favourable outcome in 90% 
patients. Gurbuz et al
18,19
 have purely favoured PFD 
with duroplasty, however, accepting that PFD with 
duroplasty have higher complications rates in the form 
of CSF leaks, pseudomeningocele and subsequent risk 
of wound infection and meningitis. 
 Statistically no significant beneficial effect of 
simple decompression or decompression with dura-
plasty was observed. Moreover, both procedures sho-
wed a favourable final outcome in more than 50% of 
patients (favourable outcome: 50% for without dura-
plasty and 50% for decompression with duraplasty). 
As is shown in a systematic review by Hankinson 
et al,
20
 there are currently no level I evidence which 
supports the notion that either procedure is signifi-
cantly superior to the other. However there are multi-
ple reports which favour the application of PFD with-
out dural opening because of the simplicity of the pro-
cedure, technically less demanding, low risk of serious 
complications and equivalent outcome as compared to 
duraplasty group.
6,21,22,23
 Individual case series such as 
one by Chotai S el al
24
has shown the favourability of 
PFD without duraplasty especially taking into account 
the higher rate of CSF related complications in the 
duraplasty group, which are more worrisome to the 
neurosurgeon. CSF related complications lead to need 
for further procedures and consequently longer morbi-
dity and prolonged longer hospital stay. Gurbuz MS 
et al
18,19
 and also some other studies
25
 have recommen-
ded PFD with duraplasty due to direct manual appro-
ach to arachnoid adhesions and removal of the patho-
physiologic barriers around the CV junction. 
 Majority of patients in our series were young adu-
lts (mean age: 32.95 ± 5.88 years) with slight male 
predominance (1.1:1). The mean symptoms duration 
was 21.62 ± 8.82 months. Clinical features included 
pain (headache, neck pain) in more than 75%, sensory 
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abnormalities in over 50% and motor problems such as 
hand weakness, gait disturbance, sphincters disturba-
nce was present in more than 45% of patients. Cranial 
nerve involvement was noted in 76% patients. Chotai 
S et al
17
 has reported a mean age of 36.6 years with 
slight female predominance. They noted syringomye-
lia in 23% of their patients which in our series was 
present in 47.6% patients. 
 PFD with and without duraplasty has also been 
compared in a series by Lee A et al
23
 who has used the 
CCOS as their outcome assessment instrument. They 
have not found significance of difference for the two 
treatment groups with a mean CCOS of 14.6 ± 0.70 
SD. Complications in our series occurred in 14% of 
patients while in Lee et al series it was noted in 19.4% 
patients while meningitis was found in 8% cases. It is 
notable that almost all CSF related complications in 
Lee et al series which is similar to our series. They 
have concluded that PFD without duraplasty is associ-
ated with significantly lower rates of postoperative 
complications (p = 0.014), although they reported a 
higher re-operation rate (p = 0.58).
23
 
 
CONCLUSION 
Posterior fossa decompression with or without dural 
opening are the most favoured procedures with equiva-
lent results in attaining symptoms relief and functional 
improvement. The most important disadvantage repor-
ted for dural opening in posterior fossa decompression 
is the high incidence of CSF related complications 
such as CSF leak, pseudomeningocele and meningitis. 
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